13.07.2015 Views

Guidelines for Complications of Cancer Treatment Vol VIII Part B

Guidelines for Complications of Cancer Treatment Vol VIII Part B

Guidelines for Complications of Cancer Treatment Vol VIII Part B

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Pulmonary Toxicity <strong>of</strong> AntineoplasticTherapyMany drugs can produce damage to the lungs, airways, pleura,and pulmonary circulation. The most common are listed inTable 1.The most common pattern is interstitial lung disease(ILD). Although drug-induced ILD accounts <strong>for</strong> only 3% <strong>of</strong>all causes <strong>of</strong> ILD, it represents an important subtype <strong>of</strong> thisdisorder, since discontinuation <strong>of</strong> the medicine may lead tosignificant improvement 1 .The diagnosis <strong>of</strong> cytotoxic lung damage depends upon anappropriate history <strong>of</strong> drug exposure, histological evidence<strong>of</strong> lung injury, and exclusion <strong>of</strong> other causes <strong>of</strong> pulmonarydisease. Because there is no single diagnostic test capable <strong>of</strong>definitively confirming the diagnosis <strong>of</strong> chemotherapyassociatedpulmonary toxicity, it remains a diagnosis <strong>of</strong>exclusion 2 .The typical clinical presentation in patients with chemotherapyinducedpulmonary fibrosis is the insidious onset <strong>of</strong> dyspnoeaand nonproductive cough. Fever is common but notconsistently present and chills are usually absent. Physicalexamination usually reveals crackles. The chest radiographmay be initially unremarkable <strong>for</strong> weeks be<strong>for</strong>e the typicaldiffuse interstitial infiltrative pattern appears. The only specific441

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!